×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GLUE – monte rosa therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GLUE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/21
02:07 pm
glue
Monte Rosa CEO Sells $141K in Stock Amid 300% Surge and Recent Capital Raise [Yahoo! Finance]
Low
Report
Monte Rosa CEO Sells $141K in Stock Amid 300% Surge and Recent Capital Raise [Yahoo! Finance]
4/21
01:59 pm
glue
Monte Rosa CEO Sells $141K in Stock Amid 300% Surge and Recent Capital Raise [Globe and Mail, The (Toronto, Canada)]
Low
Report
Monte Rosa CEO Sells $141K in Stock Amid 300% Surge and Recent Capital Raise [Globe and Mail, The (Toronto, Canada)]
4/20
07:00 am
glue
Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified Solid Tumors
Low
Report
Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified Solid Tumors
3/21
08:18 pm
glue
Monte Rosa J J Supply Deal Refocuses MRT 2359 Prostate Cancer Story [Yahoo! Finance]
Medium
Report
Monte Rosa J J Supply Deal Refocuses MRT 2359 Prostate Cancer Story [Yahoo! Finance]
3/21
01:31 am
glue
Monte Rosa Therapeutics (GLUE) was downgraded by Wall Street Zen from
Medium
Report
Monte Rosa Therapeutics (GLUE) was downgraded by Wall Street Zen from
3/18
09:17 am
glue
Monte Rosa Therapeutics (GLUE) had its price target lowered by Guggenheim from $34.00 to $30.00. They now have a "buy" rating on the stock.
Low
Report
Monte Rosa Therapeutics (GLUE) had its price target lowered by Guggenheim from $34.00 to $30.00. They now have a "buy" rating on the stock.
3/18
09:17 am
glue
Monte Rosa Therapeutics (GLUE) had its price target lowered by Wells Fargo & Company from $30.00 to $29.00. They now have an "overweight" rating on the stock.
Low
Report
Monte Rosa Therapeutics (GLUE) had its price target lowered by Wells Fargo & Company from $30.00 to $29.00. They now have an "overweight" rating on the stock.
3/18
05:17 am
glue
Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Medium
Report
Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/22
05:40 pm
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Dimension Capital I, L.P.
Medium
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Dimension Capital I, L.P.
4/16
04:07 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Medium
Report
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
4/15
04:05 pm
glue
Form 4 Monte Rosa Therapeutics, For: Apr 14 Filed by: Warmuth Markus
Low
Report
Form 4 Monte Rosa Therapeutics, For: Apr 14 Filed by: Warmuth Markus
4/14
04:40 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
Medium
Report
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
4/13
04:06 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Low
Report
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
4/10
04:08 pm
glue
Form 4 Monte Rosa Therapeutics, For: Apr 09 Filed by: Nickson Philip
Low
Report
Form 4 Monte Rosa Therapeutics, For: Apr 09 Filed by: Nickson Philip
4/9
04:06 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Nickson Philip
Medium
Report
Form 144 Monte Rosa Therapeutics, Filed by: Nickson Philip
4/8
04:08 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Medium
Report
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: